Navigation Links
First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
Date:9/17/2007

ve ingredient found in Zometa. Patients already being treated with Zometa should not be treated with Reclast. Reclast should not be used during pregnancy because of potential harm to the fetus. Reclast is not recommended for use in patients with severe renal impairment (creatinine clearance <35 mL/min) and infusion time should not be less than 15 minutes.

The most common side effects associated with Reclast are fever; pain in the muscles, bones or joints; flu-like symptoms; and headache. These symptoms usually occur within the first three days following Reclast administration and usually resolve within 3 to 4 days of onset but resolution could take up to 7 to 14 days. Patients have reported severe bone, joint and/or muscle pain after using bisphosphonates. Osteonecrosis of the jaw (ONJ) has been reported rarely in postmenopausal osteoporosis patients treated with bisphosphonates. A routine oral examination should be performed by the prescriber prior to initiation of bisphosphonate treatment. Hypocalcemia may occur with Reclast therapy.

All patients with Paget's disease should receive 1500 mg of calcium in divided doses and 800 IU of vitamin D daily, particularly in the two weeks following Reclast administration. It is recommended that patients with postmenopausal osteoporosis take calcium and vitamin D supplements, if dietary intake is not sufficient.

For more information about Reclast, visit http://www.reclast.com or call 866- RECLAST (866-732-5278).

Disclaimer

The foregoing press release contains forward-looking statements that can be identified by the use of forward-looking terminology such as "can", "will", "probably", "may", "generally follows", "expected", or similar expressions, or by express or implied discussions regarding potential future regulatory approvals of Reclast/Aclasta, or for additional indications or labeling for Reclast/Aclasta, or potential future sales of Reclast
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... DALLAS , July 3, 2015 ... report "Cardiac Monitoring & Cardiac Rhythm Management Market ... Output Monitoring, Defibrillator, Implantable Cardioverter Defibrillator, Dual Chamber ... published by MarketsandMarkets, the global Cardiac Monitoring (CM) ... poised to reach $26,646.5 Million by 2020 from ...
(Date:7/3/2015)... , July 3, 2015 Redwood ... Broda Technologies Co., Ltd., operating in both the US ... company,s proprietary IntelliGel ® supramolecular hydrogel technology in ... and other ophthalmic therapies. The Broda technology offers many ... is a free-forming liquid and with low concentrations of ...
(Date:7/2/2015)... 2, 2015 ResMed Inc. (NYSE: RMD ) ... fiscal year ended June 30, 2015 results on Thursday, July ... A press release with ResMed,s results will be issued after ... a webcast to discuss operating results and future outlook. ... p.m. US Pacific Time and the live webcast of the ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... Group Inc. (Nasdaq: WWIN ; "Winner Medical" or ... and non-woven fabric made from 100% natural PurCotton® products in ... the 2011 Brean Murray, Carret & Co. Beijing China Growth ... at the JW Marriott Hotel located at 83 Jian Guo ...
... SAN DIEGO, June 22, 2011 OncoSec Medical Incorporated ... ElectroOncology therapies to treat solid tumor cancers, announced today ... to OncoSec,s board of directors and will chair its ... For over 20 years, Dr. Maida has ...
Cached Medicine Technology:Winner Medical to Present at Brean Murray, Carret & Co. Beijing China Growth Conference 2Winner Medical to Present at Brean Murray, Carret & Co. Beijing China Growth Conference 3OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to Its Board of Directors 2OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to Its Board of Directors 3
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler ... recognition of technical sales expertise from the North American Board of Certified Energy ... is the most highly respected and well established national certification organization for renewable ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Scientists at several ... to mesothelioma with even minimal asbestos exposure. Click here to read the complete ... University of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University exposed ...
(Date:7/3/2015)... ... July 03, 2015 , ... Smoothies are all the ... good blender and easily accessible, quality ingredients. Aurora Natural is proud to introduce a ... added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is offering a ...
(Date:7/3/2015)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... truth and expose popular lies regarding proper relationships according to the bible. ... into the core of the subject by explaining why certain types of sexual relationships ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location ... Lone Star State. The premium frozen yogurt chain was listed as #22 on the ... July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy 64, Suite 200, ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... , BOULDER, Colo., Dec. 4 elephantjournal.com ... a prominent yoga teacher, talks about her journey from unrequited ... the way. , To read, visit elephantjournal.com: , http://www.elephantjournal.com/2009/11/a-new-moon-by-kathryn-budig/ ... elephantjournal.com takes a look at one young woman,s journey ...
... , , ... Bulletin Board: NGNM) announced today that Steven C. Jones ... Cardoza has joined the company as Chief Financial Officer. Mr. ... the Company. In his new role, Mr. Jones will focus ...
... , KINGFISHER, Okla., Dec. 4 United Country Lippard ... the former Kingfisher Regional Hospital, according to Troy Lippard, auctioneer. ... the South end of town," explained Lippard. "Therefore we will ... means it sells to the highest bidder with no minimums ...
... , PACIFIC PALISADES, Calif., Dec. 4 Forget ... ones something they can be proud of - beautiful, ... Women and men will love the ultimate youthful appearance ... eyes and neck combined. , Dermagenics Ultra-Intensive Anti-Wrinkle Beauty ...
... DALLAS Dec. 4, 2009 New findings by ... to treat autoimmune disorders might also help slow the ... insulin-dependent (type 1) diabetes. In type 1 ... pancreas called beta cells, which produce insulin, are destroyed ...
... had an ischemic stroke are at higher lifetime risk for ... risk. One of the simplest regimens involves antithrombotic medications, otherwise ... aspirin. But a new ... among stroke survivors increased over a seven-year period found that ...
Cached Medicine News:Health News:NeoGenomics Announces Executive Appointments 2Health News:Former Kingfisher Regional Hospital Property and Equipment to Sell at Absolute Public Auction 2Health News:Give the Gift of Beautiful Skin for the Holiday Season 2Health News:FDA-approved drug may slow beta cell destruction in type 1 diabetes patients 2Health News:Are stroke survivors taking their medicine? 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: